FDA DEVICE FACTS
Excipio SV Thrombectomy Device
Contego Medical, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Non-surgical removal of soft emboli and thrombi from peripheral blood vessels Indicated for:
• non-surgical removal of emboli and thrombi from peripheral blood vessels
• non-surgical removal of thrombi from synthetic grafts Removal of fresh, soft emboli and thrombi from vessels in the arterial system Removal of fresh, soft emboli and thrombi from vessels in the arterial system. Excipio SV Thrombectomy Device June 22, 2022 Device Name Excipio SV Thrombectomy Device ReVive PT Thrombectomy Device Penumbra Indigo Aspiration System Fogarty Arterial Embolectomy Catheter Device Subject Device Predicate Device Reference Device Reference Device
• temporary use in peripheral vessel/graft occlusion
• with aspiration and with the injection or infusion of contrast media and other fluids Principle of operation
- Thrombectomy mechanism Compressed NiTi Basket Compressed NiTi Basket Separator (for use in catheter lumen) Inflatable Balloon Expanded diameter 8 mm max 4.5mm 1.14 – 2.67 mm 4 – 14 mm Thrombectomy mechanism length 40 mm 22-28mm Unknown Unknown Artery diameters to be treated 4 – 8 mm 1.5 – 5mm Unknown 4 – 14 mm Guidewire compatibility 0.014” 0.014” 0.035” N/A Radiopaque markers Proximal and distal to basket and on basket circumference Proximal and distal to basket Unknown Barium added to catheter for radiopacity Aspiration Catheter diameter 7F or 8F N/A 3 – 8F N/A Sterilization EO E-beam Unknown Unknown
Non-Clinical Testing/Performance Data: Non-clinical laboratory testing was performed on the Excipio SV Thrombectomy Device to determine substantial equivalence. The following testing/assessment were performed:
• Visual Inspection
• Dimensional Inspection
• Kink Resistance
• Torsional Strength
• Tensile Testing
• Simulated Use Excipio SV Thrombectomy Device June 22, 2022 The in vitro bench tests demonstrated that the Excipio SV Thrombectomy Device met all acceptance criteria and performed similarly to the predicate and reference devices. Performance data demonstrate that the device functions as intended and has a safety and effectiveness profile that is similar to the predicate and reference devices.
Biocompatibility: Testing was performed to assess biocompatibility of the Excipio SV Thrombectomy Device. The following biocompatibility tests were performed:
• Cytotoxicity
• Sensitization
• Irritation
• Acute System Toxicity
• Material Mediated Pyrogenicity
• Hemolysis
• Complement Activation
• Thrombogenicity The results from the testing performed showed the Excipio SV Thrombectomy Device to be biocompatible.
GLP Animal Study: An acute GLP animal study (porcine) was conducted to evaluate in vivo thrombogenicity and acute performance and safety of the Excipio Device. The study provides evidence that the Excipio Device was usable, non- thrombogenic, and did not raise any new questions of safety in the peripheral vasculature of the porcine model. Therefore, the device is substantially equivalent to the predicate device.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。